DavidLGreenMD

PubMed

• 4 citations
  Real world prescribing practices of apixaban or rivaroxaban lead-in doses for the treatment of venous thromboembolism in hospitalized patients.
  Matthew Williams, Tania Ahuja, Veronica Raco, John Papadopoulos, David Green, Eugene Yuriditsky, Serena Arnouk> ;Journal of Thrombosis and Thrombolysis. 2022 Aug 1
• 17 citations
  Persistence of Ad26.COV2.S-associated vaccine-induced immune thrombotic thrombocytopenia (VITT) and specific detection of VITT antibodies.
  Adam J Kanack, Bandana Singh, Gemlyn George, Krishna Gundabolu, Scott A Koepsell, Mouhamed Yazan Abou-Ismail, Karen A Moser, Kristi J Smock, David Green, Ajay Major, C...> ;American Journal of Hematology. 2022 May 1
• 3 citations
  Acquired Coagulopathy and Hemorrhage Secondary to Subcutaneous Heparin Prophylaxis.
  Maria Sunseri, Tania Ahuja, Tanya Wilcox, David Green> ;Case Reports in Hematology. 2018 Jan 10
• 18 citations
  Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis
  Richard J. Lin, David Green, Gunjan L. Shah> ;The Oncologist. 2018 Apr 1
• Reply.
  Fishman, A. I.,Green, D.,Lynch, A.,Choudhury, M.,Eshghi, M.,Konno, S.> ;Urology. 2013 Jun 26
• Preventive Effect of Specific Antioxidant on Oxidative Renal Cell Injury Associated with Renal Crystal Formation
  Andrew I Fishman, Alexandria Lynch, David Green> ;Urology. 2013 Aug
• Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.
  Alexander, B.,Fishman, A. I.,Green, D.,Choudhury, M. S.,Konno, S.> ;Urol Oncol. 2013 Jan
• 37 citations
  Role of thrombin as a tumor growth factor.
  David Green, Simon Karpatkin> ;Cell Cycle. 2010 Feb 15
• 5 citations
  Effect of cancer on platelets.
  David Green, Simon Karpatkin> ;Cancer Treatment and Research. 2009 Jan 1
• Join now to see all